COASY
Bifunctional coenzyme A synthase
Also known as: COASY_HUMAN, DPCK, NBP, PPAT
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13057
- Gene
- COASY
- Ensembl
- ENSG00000068120
- Chromosome
- 17
- Canonical length
- 564 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria,Connecting piece
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
Coenzyme A (CoA) functions as a carrier of acetyl and acyl groups in cells and thus plays an important role in numerous synthetic and degradative metabolic pathways in all organisms. In eukaryotes, CoA and its derivatives are also involved in membrane trafficking and signal transduction. This gene encodes the bifunctional protein coenzyme A synthase (CoAsy) which carries out the last two steps in the biosynthesis of CoA from pantothenic acid (vitamin B5). The phosphopantetheine adenylyltransferase domain of this bifunctional protein catalyzes the conversion of 4'-phosphopantetheine into dephospho-coenzyme A (dpCoA) while its dephospho-CoA kinase domain completes the final step by phosphorylating dpCoA to form CoA. Mutations in this gene are associated with neurodegeneration with brain iron accumulation (NBIA). Alternative splicing results in multiple isoforms. [provided by RefSeq, Apr 2014]
Canonical amino-acid sequenceUniProt
564 residues, UniProt reviewed canonical sequence.
>Q13057|COASY
1 MAVFRSGLLV LTTPLASLAP RLASILTSAA RLVNHTLYVH LQPGMSLEGP AQPQSSPVQA
61 TFEVLDFITH LYAGADVHRH LDVRILLTNI RTKSTFLPPL PTSVQNLAHP PEVVLTDFQT
121 LDGSQYNPVK QQLVRYATSC YSCCPRLASV LLYSDYGIGE VPVEPLDVPL PSTIRPASPV
181 AGSPKQPVRG YYRGAVGGTF DRLHNAHKVL LSVACILAQE QLVVGVADKD LLKSKLLPEL
241 LQPYTERVEH LSEFLVDIKP SLTFDVIPLL DPYGPAGSDP SLEFLVVSEE TYRGGMAINR
301 FRLENDLEEL ALYQIQLLKD LRHTENEEDK VSSSSFRQRM LGNLLRPPYE RPELPTCLYV
361 IGLTGISGSG KSSIAQRLKG LGAFVIDSDH LGHRAYAPGG PAYQPVVEAF GTDILHKDGI
421 INRKVLGSRV FGNKKQLKIL TDIMWPIIAK LAREEMDRAV AEGKRVCVID AAVLLEAGWQ
481 NLVHEVWTAV IPETEAVRRI VERDGLSEAA AQSRLQSQMS GQQLVEQSHV VLSTLWEPHI
541 TQRQVEKAWA LLQKRIPKTH QALDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against COASY can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 66 nTPM
Expression across tissuesHPA
Tissue
- liver: 66 nTPM
- adrenal gland: 56 nTPM
- pancreas: 55 nTPM
- salivary gland: 55 nTPM
- esophagus: 51 nTPM
- kidney: 48 nTPM
Single-cell type
- hepatocytes: 115 nCPM
- cytotrophoblasts: 106 nCPM
- breast lactating cells: 105 nCPM
- syncytiotrophoblasts: 95 nCPM
- esophageal suprabasal cells: 85 nCPM
- migrating cytotrophoblasts: 79 nCPM
Immune cell
- myeloid DC: 34 nTPM
- intermediate monocyte: 32 nTPM
- classical monocyte: 30 nTPM
- eosinophil: 27 nTPM
- total PBMC: 24 nTPM
- plasmacytoid DC: 24 nTPM
Brain region
- pons: 37 nTPM
- choroid plexus: 34 nTPM
- cerebral cortex: 33 nTPM
- thalamus: 33 nTPM
- medulla oblongata: 32 nTPM
- hippocampal formation: 31 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about COASY.
Disease | AllUniProt
Conditions COASY is implicated in, by any mechanism.
- Neurodegeneration with brain iron accumulation 6 (NBIA6) MIM:615643
- Pontocerebellar hypoplasia 12 (PCH12) MIM:618266
Disease | GeneticClinVar
31 pathogenic / likely-pathogenic of 411 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodegeneration with brain iron accumulation 6
- Pontocerebellar hypoplasia, type 12
- Neurodegeneration with brain iron accumulation
- COASY-Related Disorders
- Neurodegeneration with brain iron accumulation 2B
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.03
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.11
- DepMap mean gene effect
- -0.49
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- ATP binding
- dephospho-CoA kinase activity
- pantetheine-phosphate adenylyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of COASY in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads COASY as an antibody target. Whether an autoantibody or antibody against COASY could matter depends on whether native COASY is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
COASY is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label COASY as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...